REGULATORY
MHLW to Urge Insurers to Promote Generic Use among Beneficiaries of High-Cost Healthcare Benefit System
The Ministry of Health, Labor and Welfare (MHLW) plans to encourage insurers to promote the use of generic drugs by patients receiving benefits under the high-cost healthcare benefit system before the end of this month. In order to promote the…
To read the full story
Related Article
REGULATORY
- Japan Likely to Extend Generic-Name Prescribing Premium to Biologics to Spur Biosimilars
December 8, 2025
- Aspirin, CAR-T and Other Products under PMDA Safety Review
December 8, 2025
- R&D Tax Credit Draws Broad Calls for Maintenance, Expansion: LDP Meeting
December 8, 2025
- Another LDP Study Group Submits Emergency Proposal Urging Drug Pricing Overhaul
December 5, 2025
- Ishin Urges Takaichi to Revisit OTC-Like Drug Coverage, Softens Savings Target
December 5, 2025
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…





